{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:41:12Z","timestamp":1773103272083,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tjog.2025.04.017","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:17:47Z","timestamp":1757513867000},"page":"868-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advanced high-grade serous carcinoma of the ovary after IVF treatment in a 38-year-old nulligravida: A case report of diagnostic challenges in the presence of OHSS"],"prefix":"10.1016","volume":"64","author":[{"given":"Yun-Yao","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tjog.2025.04.017_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.14684","article-title":"Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention","volume":"45","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.tjog.2025.04.017_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-016-0192-7","article-title":"Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites","volume":"8","author":"Dietrich","year":"2016","journal-title":"Clin Epigenet"},{"issue":"4","key":"10.1016\/j.tjog.2025.04.017_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.tjog.2025.04.017_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/09513590.2019.1653275","article-title":"Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients","volume":"36","author":"Du","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"10.1016\/j.tjog.2025.04.017_bib5","first-page":"330","article-title":"The diagnostic work-up in patients with ascites: current guidelines and future prospects","volume":"74","author":"Oey","year":"2016","journal-title":"Neth J Med"},{"issue":"5","key":"10.1016\/j.tjog.2025.04.017_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hep.1840080521","article-title":"Ascitic fluid analysis in malignancy-related ascites","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.tjog.2025.04.017_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13048-020-00624-9","article-title":"Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)","volume":"13","author":"Farkas","year":"2020","journal-title":"J Ovarian Res"},{"issue":"11","key":"10.1016\/j.tjog.2025.04.017_bib8","article-title":"Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis","volume":"58","author":"S\u00f8rensen","year":"2011","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.tjog.2025.04.017_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/bs.vh.2018.01.018","article-title":"The ovarian hyperstimulation syndrome","volume":"107","author":"Blumenfeld","year":"2018","journal-title":"Vitam Horm"},{"key":"10.1016\/j.tjog.2025.04.017_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1757-2215-7-54","article-title":"Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study","volume":"7","author":"Nouri","year":"2014","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.tjog.2025.04.017_bib11","article-title":"Comprehensive management of polycystic ovarian syndrome and secondary infertility: Optimizing fertility outcomes","volume":"16","author":"Khemani","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.tjog.2025.04.017_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1477-7827-11-91","article-title":"Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy","volume":"11","author":"Hatzipetros","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"10.1016\/j.tjog.2025.04.017_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11523-023-00970-w","article-title":"PARP inhibitors in ovarian cancer: A review","volume":"18","author":"O'Malley","year":"2023","journal-title":"Targeted Oncol"},{"issue":"10","key":"10.1016\/j.tjog.2025.04.017_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.tjog.2025.04.017_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54295-x","article-title":"Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer","volume":"15","author":"Elorbany","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.tjog.2025.04.017_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.tjog.2025.04.017_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.fertnstert.2024.03.026","article-title":"Fertility drugs and cancer: a guideline","volume":"122","year":"2024","journal-title":"Fertil Steril"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455925001901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455925001901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:19:06Z","timestamp":1757513946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455925001901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1028455925001901"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2025.04.017","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced high-grade serous carcinoma of the ovary after IVF treatment in a 38-year-old nulligravida: A case report of diagnostic challenges in the presence of OHSS","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2025.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}